NCT03329443View on ClinicalTrials.gov

The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography

PHASE2CompletedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 4, 2018

Conditions
Acute Kidney InjuryIHDContrast-induced Nephropathy
Interventions
DRUG

Spironolactone

each patient will receive 200 mg of spironolactone as per his/her angiography premedications

DRUG

Placebo Oral Tablet

Each patient will receive a placebo tablet as per his/her angiography premedications

Trial Locations (1)

00964

Al-Sader Teaching Hospital, Basra

All Listed Sponsors
collaborator

Ministry of Health-Basra Health Directorate-Al-Sader Teaching Hospital

UNKNOWN

lead

Alhasan Mujtaba Abdul-Wahid

OTHER

NCT03329443 - The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography | Biotech Hunter | Biotech Hunter